Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Mandl

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Analytical and Bioanalytical Chemistry|April 4, 2023
Coherent diffractive imaging of proteins and viral capsids: simulating MS SPIDOCThomas Kierspel, Alan Kadek, Perdita Barran, et al.
Rheumatology (Oxford, England)|December 18, 2024
A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren's diseaseCecilia Fugmann, Sarah Reid, Pascal Pucholt, et al.
Annals of the Rheumatic Diseases|December 12, 2025
A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren's diseaseAlbin Björk, Johannes Mofors, Lauro Meneghel, et al.
Drugs & Aging|February 23, 2021
Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren's SyndromeSoledad Retamozo, Chiara Baldini, Hendrika Bootsma, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)Raphaèle Seror, Elke Theander, Johan G Brun, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2022
Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's SyndromeChristian Lundtoft, Christopher Sjöwall, Solbritt Rantapää-Dahlqvist, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 16, 2024
Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune DiseasesMatteo Bianchi, Sergey V Kozyrev, Antonella Notarnicola, et al.
Annals of the Rheumatic Diseases|December 7, 2014
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)Raphaèle Seror, Hendrika Bootsma, Alain Saraux, et al.
Rheumatology (Oxford, England)|September 5, 2020
Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndromeGuðný Ella Thorlacius, Lina Hultin-Rosenberg, Johanna K Sandling, et al.
Rheumatology (Oxford, England)|January 25, 2021
Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 childrenManuel Ramos-Casals, Nihan Acar-Denizli, Arjan Vissink, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Analytical and Bioanalytical Chemistry|April 4, 2023
Coherent diffractive imaging of proteins and viral capsids: simulating MS SPIDOCThomas Kierspel, Alan Kadek, Perdita Barran, et al.
Rheumatology (Oxford, England)|December 18, 2024
A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren's diseaseCecilia Fugmann, Sarah Reid, Pascal Pucholt, et al.
Annals of the Rheumatic Diseases|December 12, 2025
A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren's diseaseAlbin Björk, Johannes Mofors, Lauro Meneghel, et al.
Drugs & Aging|February 23, 2021
Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren's SyndromeSoledad Retamozo, Chiara Baldini, Hendrika Bootsma, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)Raphaèle Seror, Elke Theander, Johan G Brun, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2022
Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's SyndromeChristian Lundtoft, Christopher Sjöwall, Solbritt Rantapää-Dahlqvist, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 16, 2024
Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune DiseasesMatteo Bianchi, Sergey V Kozyrev, Antonella Notarnicola, et al.
Annals of the Rheumatic Diseases|December 7, 2014
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)Raphaèle Seror, Hendrika Bootsma, Alain Saraux, et al.
Rheumatology (Oxford, England)|September 5, 2020
Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndromeGuðný Ella Thorlacius, Lina Hultin-Rosenberg, Johanna K Sandling, et al.
Rheumatology (Oxford, England)|January 25, 2021
Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 childrenManuel Ramos-Casals, Nihan Acar-Denizli, Arjan Vissink, et al.
Pageof 8